After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

74 trades

Disclosure transactions for Enliven Therapeutics
Reporting person Filed Transaction Transaction value Source Actions
Collins Helen Louise Chief Medical Officer Jun 22, 2026 5-day lag Exercise Jun 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Hohl Benjamin Chief Financial Officer Jun 22, 2026 5-day lag Sale Jun 17, 2026 $59K Filed shares x price SEC Form 4 View filing
Hohl Benjamin Chief Financial Officer Jun 22, 2026 5-day lag Exercise Jun 17, 2026 $14.92K Filed shares x price SEC Form 4 View filing
Hohl Benjamin Chief Financial Officer Jun 22, 2026 5-day lag Sale Jun 17, 2026 $149.18K Filed shares x price SEC Form 4 View filing
Collins Helen Louise Chief Medical Officer Jun 22, 2026 5-day lag Sale Jun 17, 2026 $50.69K Filed shares x price SEC Form 4 View filing
Collins Helen Louise Chief Medical Officer Jun 22, 2026 5-day lag Exercise Jun 17, 2026 $12.4K Filed shares x price SEC Form 4 View filing
Hohl Benjamin Chief Financial Officer Jun 22, 2026 5-day lag Sale Jun 17, 2026 $55.4K Filed shares x price SEC Form 4 View filing
Collins Helen Louise Chief Medical Officer Jun 22, 2026 5-day lag Sale Jun 17, 2026 $54.3K Filed shares x price SEC Form 4 View filing
Hohl Benjamin Chief Financial Officer Jun 22, 2026 5-day lag Exercise Jun 17, 2026 $0 Filed shares x price SEC Form 4 View filing
Orbimed Advisors Llc 10% owner Jun 17, 2026 2-day lag Sale Jun 15, 2026 $409.05K Filed shares x price SEC Form 4 View filing
Orbimed Advisors Llc 10% owner Jun 17, 2026 2-day lag Sale Jun 15, 2026 $12.26M Filed shares x price SEC Form 4 View filing
Kunkel Lori Anne Director Jun 9, 2026 4-day lag Sale Jun 5, 2026 $266.66K Filed shares x price SEC Form 4 View filing
Kunkel Lori Anne Director Jun 9, 2026 4-day lag Sale Jun 5, 2026 $12.68K Filed shares x price SEC Form 4 View filing
Kunkel Lori Anne Director Jun 9, 2026 4-day lag Sale Jun 5, 2026 $66.01K Filed shares x price SEC Form 4 View filing
Collins Helen Louise Chief Medical Officer
Exercise
Calculated transaction value
$0 5,000 shares @ $0
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Hohl Benjamin Chief Financial Officer
Sale
Calculated transaction value
$59K 1,379 shares @ $42.78
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Hohl Benjamin Chief Financial Officer
Exercise
Calculated transaction value
$14.92K 6,018 shares @ $2.48
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Hohl Benjamin Chief Financial Officer
Sale
Calculated transaction value
$149.18K 3,401 shares @ $43.86
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Collins Helen Louise Chief Medical Officer
Sale
Calculated transaction value
$50.69K 1,133 shares @ $44.74
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Collins Helen Louise Chief Medical Officer
Exercise
Calculated transaction value
$12.4K 5,000 shares @ $2.48
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Hohl Benjamin Chief Financial Officer
Sale
Calculated transaction value
$55.4K 1,238 shares @ $44.75
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Collins Helen Louise Chief Medical Officer
Sale
Calculated transaction value
$54.3K 1,268 shares @ $42.83
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Hohl Benjamin Chief Financial Officer
Exercise
Calculated transaction value
$0 6,018 shares @ $0
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Orbimed Advisors Llc 10% owner
Sale
Calculated transaction value
$409.05K 9,086 shares @ $45.02
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Orbimed Advisors Llc 10% owner
Sale
Calculated transaction value
$12.26M 272,322 shares @ $45.02
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Kunkel Lori Anne Director
Sale
Calculated transaction value
$266.66K 7,779 shares @ $34.28
Traded
Jun 5, 2026
Filed
Jun 9, 2026
Kunkel Lori Anne Director
Sale
Calculated transaction value
$12.68K 354 shares @ $35.82
Traded
Jun 5, 2026
Filed
Jun 9, 2026
Kunkel Lori Anne Director
Sale
Calculated transaction value
$66.01K 1,867 shares @ $35.36
Traded
Jun 5, 2026
Filed
Jun 9, 2026